+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 4Years - 8Years
All Genders
ID07488416

Comparing Zinc Oxide with 6-Gingerol Mix and Triple Antibiotic Paste for Treating Non-vital Primary Molars in Children Aged 4 to 8 Years

Led by Al-Azhar University · Updated on 2026-03-23

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare the clinical and radiographic outcomes of two treatments for non-vital primary molars in children aged 4 to 8 years. It focuses on evaluating Lesion Sterilization and Tissue Repair LSTR using a zinc oxide and 6-gingerol mix against the conventional triple antibiotic paste. The study addresses challenges in treating primary teeth affected by dental caries and periapical changes that often limit conventional endodontic options and may lead to tooth extraction. The trial involves two groups one receiving LSTR treatment with the zinc oxide6-gingerol mix and the other treated with the triple antibiotic paste. Both treatments aim to disinfect the root canals and promote tissue repair using minimal instrumentation. This approach offers a less invasive alternative to extraction for affected primary molars. Participants will be monitored for clinical signs such as pain and tooth mobility, with pain assessed six months after treatment and tooth mobility evaluated after one year. The study includes regular clinical and radiographic evaluations to track treatment progress and outcomes. The total participation period covers at least one year to observe these effects and safety signals.

CONDITIONS

Brief Title

Clinical and Radiographic Outcomes of Lesion Sterilization and Tissue Repair Using Zinc Oxide/ 6-gingerol Mix Versus Triple Antibiotic Paste in Non-vital Primary Molars

Research Team

A

Ahmed E El-Metwally, MBBCH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here